YOLFTbeta
Bluejay Diagnostics Inc

Bluejay Diagnostics Inc

BJDX · NASDAQ · Healthcare / Medical Devices

2.61USD+0.00 (+0.19%)

Price History

Full chart

Market Stats

Previous Close2.61
Open2.44
Day Range2.44 – 3.04
52-Week Range0.80 – 16.68
Volume37.03K
Market Cap982.98K
P/E (TTM)0.00
Forward P/E0.00
EPS-2.27
Dividend Yield0.00%
Beta0.91
50-Day Avg0.997
200-Day Avg2.19

About

Bluejay Diagnostics, Inc. operates as a medical diagnostics company. It offers Symphony technology platform which consists of an analyzer and single-use protein detection cartridges that are designed to provide measurements of key diagnostic biomarkers found in blood; and Symphony analyzer used to orchestrate sample processing of whole blood, plasma, serum, etc., biomarker isolation, and immunoassay preparation using non-contact centrifugal force. The company also develops Symphony IL-6 tests for the monitoring of disease progression in critical care settings. In addition, it develops additional tests for Symphony, such as tests for myocardial infraction and congestive heart failure, as well as other tests using the Symphony platform. Bluejay Diagnostics, Inc. was incorporated in 2015 and is headquartered in Acton, Massachusetts.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Indranil Dey
  • Employees6
  • Headquarters360 Massachusetts Avenue, Acton, MA, United States, 01720, USA
  • Websitehttps://bluejaydx.com

Leadership

  • Mr. Indranil DeyPrincipal Financial, Accounting & Executive Officer, President, CEO and Director · b. 1964
  • Mr. Kevin VanceChief Commercial Officer · b. 1958
  • Mr. Mark W. Feinberg M.D., Ph.D.Chief Medical Advisor
  • Dr. Mark W. Feinberg M.D.Chief Medical Advisor

Financials

Income Statement

Currency: USD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue0075249.04K000
Growth (%)---+331953.33%-100.00%--
Cost of Revenue142.97K157.04K145.72K200.13K780.96K199.10K170.68K
Gross Profit-142.97K-157.04K-145.72K48.91K-780.96K-199.10K-170.68K
Gross Margin---194292.00%19.64%---
Operating Expense1.49M1.04M3.08M9.37M9.53M6.97M6.78M
Operating Income-1.63M-1.20M-3.23M-9.32M-10.31M-7.17M-6.95M
Operating Margin---4306884.00%-3741.48%---
EBITDA-1.49M-1.04M-2.98M-8.99M-9.17M-6.70M-6.68M
EBITDA Margin---3966826.67%-3610.09%---
Net Income-757.72K-1.13M-3.73M-9.30M-9.95M-7.72M-6.85M
Net Income Margin---4972914.67%-3733.11%---
R&D454.61K527.25K1.15M4.15M5.71M3.47M3.05M
R&D as % of Total Revenue--1530606.67%1667.26%---
Interest Expense027.00K367.46K20.83K0823.03K839
Interest Expense % of Total Revenue--489945.33%8.36%---

Balance Sheet

Currency: USD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets916.52K1.52M21.02M13.52M4.87M6.66M7.12M
Total Liabilities3.85M5.72M637.16K1.98M1.97M927.92K1.14M
Total Equity-2.93M-4.21M20.38M11.54M2.89M5.73M5.98M
Cash96.01K912.36K19.05M10.11M2.21M4.30M5.16M
Total Debt1.07M1.06M-492.62K352.98K222.25K120.21K
Net Debt973.28K143.55K-19.05M-9.62M-1.86M-4.08M-5.04M

Cash Flow

Currency: USD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-1.69M-508.71K-4.37M-7.74M-8.31M-7.82M-6.05M
Investing Cash Flow-6.02K-23.95K-23.95K-1.20M-704.17K-306.78K-173.74K
Financing Cash Flow1.51M1.33M22.53M8.07K1.11M10.22M7.09M
Capital Expenditure6.02K23.95K23.95K1.20M704.17K306.78K173.74K
Free Cash Flow-1.70M-508.71K-4.39M-8.94M-9.02M-8.13M-6.23M
Dividends Paid--17.67K----
FCF to OCF100.36%100.00%100.55%115.49%108.47%103.92%102.87%
Dividend Paid to FCF---0.40%----

Earnings

Report DateMar 31, 2020Jun 30, 2020Sep 30, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 16, 2021Mar 10, 2022Apr 20, 2022Jul 26, 2022Nov 8, 2022Mar 20, 2023May 10, 2023Aug 14, 2023Nov 9, 2023Mar 28, 2024May 15, 2024Aug 14, 2024Nov 29, 2024Mar 31, 2025May 13, 2025Aug 7, 2025Nov 7, 2025Mar 24, 2026May 29, 2026Aug 12, 2026Nov 6, 2026
EPS Estimate0.000.000.000.000.000.000.00--0.11-0.08-0.080.04-0.06-2240.00-1344.00-1360.00----0.09-0.000.00----
EPS Actual-0.02-0.02-0.01-0.10-0.10-0.11-0.09-0.09-0.10-0.10-0.15-0.12-0.12-4400.00-3328.00-2848.00-7.90-1024.65-31.02-27.81-3.37-1.41-1.01-2.37-1.95-1.12-
Surprise--------9.09%-25.00%-87.50%-400.00%-100.00%-96.43%-147.62%-109.41%----30800.00%-------
Timing------Pre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hours----------

Key Statistics & Ratios

Market Cap982.98K
Enterprise Value-8.52M
Trailing P/E0.00
Forward P/E0.00
Price / Sales54.99
Price / Book0.11
EPS-2.27
Book Value4.75
Revenue (TTM)0
Gross Profit (TTM)48.91K
EBITDA-7.24M
Profit Margin0.00%
Operating Margin0.00%
Return on Equity-98.89%
Return on Assets-51.08%
Shares Outstanding1.03M
Shares Float4.38M
Beta0.91
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Ownership Breakdown

Institutions
9.79%
Insiders
2.03%
Retail / Other
88.18%

Top Institutional Holders

  • Sabby Management LLC
    28.73K2.78%
  • Geode Capital Management, LLC
    28.13K2.72%
  • Tower Research Capital LLC
    1.73K0.17%
  • UBS Group AG
    1240.01%
  • L1 Global Manager Pty Ltd
    1200.01%
  • Caitong International Asset Management Co., Limited.
    30.00%
  • Meteora Capital, LLC
    00.00%
  • Bank of America Corp
    00.00%

Top Fund Holders

  • Fidelity Extended Market Index
    5.67K0.13%
  • Fidelity Series Total Market Index
    1830.00%

Dividends

20231×
0.10Jul 24, 2023

Stock Splits

  • Nov 3, 20261:4
  • Jan 29, 20261:4
  • Nov 18, 20241:50
  • Jun 20, 20241:8
  • Jul 24, 20231:20